Published in PLoS One on April 05, 2013
Immunological Parameters Associated With Vitiligo Treatments: A Literature Review Based on Clinical Studies. Autoimmune Dis (2015) 0.81
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Pluripotency of mesenchymal stem cells derived from adult marrow. Nature (2002) 19.57
A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell (2008) 18.18
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood (2002) 9.40
Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell (2008) 7.47
Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol (2001) 7.20
Immunomodulatory properties of mesenchymal stromal cells. Blood (2007) 6.97
Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature (1988) 5.99
Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation (2003) 5.07
Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood (2006) 3.52
The weight of leptin in immunity. Nat Rev Immunol (2004) 3.24
Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells (2005) 3.15
Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell (2012) 2.87
High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J Exp Med (1998) 2.58
Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain (1995) 1.92
Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res (2003) 1.90
Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J Immunol (1998) 1.81
The human adipose tissue is a source of multipotent stem cells. Biochimie (2005) 1.70
Mesenchymal stem cells induce apoptosis of activated T cells. Leukemia (2005) 1.63
Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol (2009) 1.56
Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders. Stem Cells Dev (2010) 1.50
Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo. Lab Invest (2003) 1.41
Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest (2000) 1.39
Contribution of antigen-primed CD8+ T cells to the development of airway hyperresponsiveness and inflammation is associated with IL-13. J Immunol (2004) 1.30
Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow. Cytometry B Clin Cytom (2006) 1.22
An immunohistological study of cutaneous lymphocytes in vitiligo. J Pathol (1993) 1.21
The role of oxidants and antioxidants in generalized vitiligo. J Dermatol (2003) 1.19
A systematic review of autologous transplantation methods in vitiligo. Arch Dermatol (1998) 1.16
Vitiligo, reactive oxygen species and T-cells. Clin Sci (Lond) (2011) 1.14
Study of clinical, biochemical and immunological factors determining stability of disease in patients with generalized vitiligo undergoing melanocyte transplantation. Br J Dermatol (2012) 1.13
Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells. Arch Dermatol (1995) 1.12
Therapeutic implications of autoimmune vitiligo T cells. Autoimmun Rev (2006) 1.12
The role of oxidants and antioxidants in generalized vitiligo at tissue level. J Eur Acad Dermatol Venereol (2004) 1.11
New insights and new therapies in vitiligo. JAMA (2005) 1.09
Propagation, expansion, and multilineage differentiation of human somatic stem cells from dermal progenitors. Stem Cells Dev (2005) 1.05
Vitiligo: pathogenetic hypotheses and targets for current therapies. Curr Drug Metab (2010) 1.01
A comparative study of oxidant-antioxidant status in stable and active vitiligo patients. Arch Dermatol Res (2006) 0.98
CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis. Mol Med Rep (2012) 0.90
Initiation and regulation of CD8+T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo. Eur J Cell Biol (2004) 0.90
Treatment of vitiligo in children and adolescents by autologous cultured pure melanocytes transplantation with comparison of efficacy to results in adults. J Eur Acad Dermatol Venereol (2011) 0.86
Human neonatal thymus-derived mesenchymal stromal cells: characterization, differentiation, and immunomodulatory properties. Tissue Eng Part A (2009) 0.85
Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation. Br J Dermatol (2011) 0.84
Immune-mediated destruction of melanocytes in halo nevi is associated with the local expansion of a limited number of T cell clones. J Immunol (1999) 0.84
Immunomodulatory properties of porcine, bone marrow-derived multipotent mesenchymal stromal cells and comparison with their human counterpart. Cell Mol Biol (Noisy-le-grand) (2011) 0.76
A case of vitiligo induced by tattooing eyebrow. Int J Dermatol (2011) 1.54
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells. BMC Cancer (2014) 1.52
Cytosolic dsDNA triggers apoptosis and pro-inflammatory cytokine production in normal human melanocytes. Exp Dermatol (2015) 1.42
SIRT1 confers protection against UVB- and H2O2-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes. J Cell Mol Med (2008) 1.24
EGFR activation confers protections against UV-induced apoptosis in cultured mouse skin dendritic cells. Cell Signal (2008) 1.06
alpha-MSH activates immediate defense responses to UV-induced oxidative stress in human melanocytes. Pigment Cell Melanoma Res (2009) 1.04
Minocycline protects melanocytes against H2O2-induced cell death via JNK and p38 MAPK pathways. Int J Mol Med (2008) 0.95
Genetic epidemiology of vitiligo: a study of 815 probands and their families from south China. Int J Dermatol (2006) 0.92
CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis. Mol Med Rep (2012) 0.90
Primary cutaneous extranodal NK/T-cell lymphoma, nasal type, in an adolescent. Eur J Dermatol (2009) 0.89
Nicotinamide attenuates aquaporin 3 overexpression induced by retinoic acid through inhibition of EGFR/ERK in cultured human skin keratinocytes. Int J Mol Med (2008) 0.89
Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin. PLoS One (2012) 0.88
Spontaneous regression of generalized eruptive histiocytosis: possible involvement of apoptosis? Int J Dermatol (2007) 0.88
T-2 toxin-induced apoptosis involving Fas, p53, Bcl-xL, Bcl-2, Bax and caspase-3 signaling pathways in human chondrocytes. J Zhejiang Univ Sci B (2008) 0.84
A randomized controlled study of the effects of different modalities of narrow-band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo. Dermatol Surg (2014) 0.83
The changes of microRNA expression profiles and tyrosinase related proteins in MITF knocked down melanocytes. Mol Biosyst (2012) 0.81
Tumor necrosis factor-alpha-308G/A promoter polymorphism is associated with the susceptibility of polymyositis/dermatomyositis in a Chinese Han population. J Dermatol (2007) 0.81
Niacin protects against UVB radiation-induced apoptosis in cultured human skin keratinocytes. Int J Mol Med (2012) 0.80
The role of VIT1/FBXO11 in the regulation of apoptosis and tyrosinase export from endoplasmic reticulum in cultured melanocytes. Int J Mol Med (2010) 0.80
[Protective effect of selenium against T-2 toxin-induced inhibition of chondrocyte aggrecan and collagen II synthesis]. Nan Fang Yi Ke Da Xue Xue Bao (2006) 0.79
Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a case report. Int J Dermatol (2009) 0.78
VIT1/FBXO11 knockdown induces morphological alterations and apoptosis in B10BR mouse melanocytes. Int J Mol Med (2009) 0.77
A case report of Dubowitz syndrome accompanied by congenital anal atresia. Int J Dermatol (2010) 0.77
A mouse model of vitiligo induced by monobenzone. Exp Dermatol (2013) 0.76
[Impact on tyrosinase expression and export from endoplasmic reticulum by inhibition of 26S proteasome]. Zhonghua Yi Xue Za Zhi (2013) 0.76
Transplantation of autologous minigrafts for the treatment of large-area segmental vitiligo. J Dermatolog Treat (2009) 0.75
The effect of combined calcipotriol and betamethasone dipropionate ointment in the treatment of vitiligo: an open, uncontrolled trial. J Drugs Dermatol (2012) 0.75
[Epidemiologic and clinical characteristics of 59 persons suspecting of being infected by the HIV virus despite having repeated negative laboratory findings]. Zhonghua Liu Xing Bing Xue Za Zhi (2010) 0.75
[Construction, expression and immunogenicity analysis of a fusion protein containing M2e of influenza A virus fused to a modified Pseudomonas aeruginosa exotoxin A]. Bing Du Xue Bao (2010) 0.75
Follow-up study of vitiligo patients treated with autologous epidermal sheet transplants. J Dermatolog Treat (2013) 0.75
[Study on the inhibition effect of siRNA on herpes simplex virus type 2 ICP4 gene]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi (2010) 0.75
[Subcloning of M1 gene fragment of H5N1 influenza virus and its expression in Escherichia coli]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi (2011) 0.75
[Screening for new binding proteins which interact with BM2 of influenza B virus with yeast two-hybrid system]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi (2005) 0.75
Transferable crosslinked chitosan membranes for human melanocyte culture. J Biomed Mater Res A (2011) 0.75
[Effect of mouse uroplakin II promoter on human bladder cancer cell line]. Zhonghua Zhong Liu Za Zhi (2004) 0.75
[Phase transition behavior and thermodynamic analysis of hydrotalcite flame-retardant]. Guang Pu Xue Yu Guang Pu Fen Xi (2015) 0.75
In vivo confocal laser scanning microscopy of hypopigmented macules: a preliminary comparison of confocal images in vitiligo, nevus depigmentosus and postinflammatory hypopigmentation. Lasers Med Sci (2010) 0.75
Long-term follow-up and correlated factors of vitiligo following autologous epidermal transplantation. Cutis (2011) 0.75
Epigallocatechin-3-gallate (EGCG) Suppresses the Trafficking of Lymphocytes to Epidermal Melanocytes via Inhibition of JAK2: Its Implication for Vitiligo Treatment. Biol Pharm Bull (2015) 0.75
Immunodetection of the MCHR1 antibody in vitiligo patient sera. Int J Mol Med (2011) 0.75
Transplantation of autologous minigrafts for the treatment of stable vitiligo. J Dermatolog Treat (2011) 0.75
[Study on preparation and identification of monoclonal antibodies immunized with H5N1 influenza virus M1 protein]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi (2009) 0.75
[Effects of human HSF1 on transcriptional regulation of prohibitin promoter]. Zhongguo Ying Yong Sheng Li Xue Za Zhi (2009) 0.75
[Genetic analysis of NS1 fragment of human H5N1 influenza virus isolated in Anhui province and its expression in Escherichia coli]. Wei Sheng Wu Xue Bao (2007) 0.75
[Application of the branched multiple antigenic peptide system in the development of vaccine]. Bing Du Xue Bao (2011) 0.75
[Expression of InnVit/FBXO11 in vitiligo and its role in tyrosinase export from endoplasmic reticulum]. Zhonghua Yi Xue Za Zhi (2010) 0.75
Melagenine modulates proliferation and differentiation of melanoblasts. Int J Mol Med (2008) 0.75